Moneycontrol PRO
ajanta pharmaceuticals
Jump to
10 Results Found
  • Buy Ajanta Pharmaceuticals; target of Rs 2250: ICICI Direct May 25, 2021 03:53 PM IST

    Buy Ajanta Pharmaceuticals; target of Rs 2250: ICICI Direct

    ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2250 in its research report dated May 01, 2021.

  • Buy Ajanta Pharmaceuticals; target of Rs 1960: ICICI Direct Nov 07, 2020 12:54 PM IST

    Buy Ajanta Pharmaceuticals; target of Rs 1960: ICICI Direct

    ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1960 in its research report dated November 04, 2020.

  • Buy Ajanta Pharmaceuticals; target of Rs 1810: ICICI Direct Aug 03, 2020 12:36 PM IST

    Buy Ajanta Pharmaceuticals; target of Rs 1810: ICICI Direct

    ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1810 in its research report dated July 31, 2020.

  • Buy Ajanta Pharmaceuticals; target of Rs 1730: ICICI Direct May 25, 2020 09:46 PM IST

    Buy Ajanta Pharmaceuticals; target of Rs 1730: ICICI Direct

    ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1730 in its research report dated May 22, 2020.

  • Hold Ajanta Pharmaceuticals; target of Rs 1010: ICICI Direct Aug 02, 2019 11:11 AM IST

    Hold Ajanta Pharmaceuticals; target of Rs 1010: ICICI Direct

    ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1010 in its research report dated August August 01, 2019.

  • Ajanta Pharma bets on India, US markets to beat African tenders slowdown Jul 19, 2019 09:55 PM IST

    Ajanta Pharma bets on India, US markets to beat African tenders slowdown

    The company, a major player in anti-malarial drugs in Africa, saw its business decline by 49 percent in FY19 compared to the previous year due to softening of tender business.

  • Hold Ajanta Pharmaceuticals; target of Rs 1060: ICICI Direct May 03, 2019 01:39 PM IST

    Hold Ajanta Pharmaceuticals; target of Rs 1060: ICICI Direct

    ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1060 in its research report dated May 02, 2019.

  • Hold Ajanta Pharmaceuticals; target of Rs 1100: ICICI Direct Feb 19, 2019 05:41 PM IST

    Hold Ajanta Pharmaceuticals; target of Rs 1100: ICICI Direct

    ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1100 in its research report dated February 01, 2019.

  • Hold Ajanta Pharmaceuticals; target of Rs 1190: ICICI Direct May 15, 2018 05:48 PM IST

    Hold Ajanta Pharmaceuticals; target of Rs 1190: ICICI Direct

    ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1190 in its research report dated May 03, 2018.

  • Dabur in talks to buy Ajanta's 30-plus brand - report May 02, 2011 01:54 PM IST

    Dabur in talks to buy Ajanta's 30-plus brand - report

    Dabur India is in talks to buy the 30-Plus multi-vitamin supplement brand from Ajanta Pharmaceuticals for less than 500 million rupees, the Economic Times reported on Monday.

Sections
ISO 27001 - BSI Assurance Mark